Laura Carenzi
Pavia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Effectiveness of an adapted Interdisciplinary Orofacial Examination Protocol for Children and Adolescents for the Early Identification of Speech Disorders in Paediatric Orthodontic Patients.
Journal: European journal of paediatric dentistry
Published: December 12, 2025
A Multicenter Study in Northern Italy to Evaluate the Impact of a Sepsis Bundle in Obstetric Settings: The SOS Study.
Journal: Open forum infectious diseases
Published: November 16, 2024
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project.
Journal: Infection and drug resistance
Published: May 08, 2018
Strategic use of dual regimens of boosted protease inhibitors plus maraviroc in poorly adherent subjects in view of long-acting drugs: A retrospective study.
Journal: Medicine
Published: February 17, 2017
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.
Journal: Infection
Published: January 17, 2016
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance.
Journal: International journal of antimicrobial agents
Published: July 22, 2014
Gender differences in HIV infection: is there a problem? Analysis from the SCOLTA cohorts.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 22, 2013
Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study.
Journal: American journal of hypertension
Published: October 01, 2013
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study.
Journal: International journal of antimicrobial agents
Published: July 27, 2013
Four years of immunization with OM-85 BV to prevent respiratory infections in HIV+ patients.
Journal: Human vaccines & immunotherapeutics
Published: June 25, 2013
Last Updated: 09/26/2026